Russia's JSC Isotop has launched domestic supply of Rakurs (223Ra), a radiopharmaceutical for treating bone metastases.

Explore the latest strategies for selecting treatment regimens in HER2-positive breast cancer, focusing on safety and patient-specific factors.

The Chinese biopharmaceutical company shared its recent innovations and strategic roadmap at the prestigious annual healthcare investment gathering, highlighting its development pipeline and growth ...

From January 12 to 15, 2026, the 44th J.P. Morgan Healthcare Conference (JPMHC) was held in San Francisco, California, USA. Dr. Ge Michael, President and CEO of Sichuan Kelun-Biotech Biopharmaceutical ...

Detailed price information for Bicycle Therapeutics Plc ADR (BCYC-Q) from The Globe and Mail including charting and trades.

Following Guidance from the European Medicines Agency’s (EMA) Scientific Advice Working Party (SAWP) Regarding Iopofosine I 131 for the Treatment of Waldenstrom’s Macroglobulinemia (WM), Expects to ...

Aktis Oncology’s IPO will support a pipeline of “miniprotein” radioconjugates that could offer advantages over other targeted ...

As Novartis turns the calendar on a new year, the Swiss drugmaker is elaborating further on plans for the $23 billion U.S. investment it unveiled last April. Next on the docket will be a new, ...

Meanwhile, another $70 million to $80 million of the IPO proceeds is expected to fund the launch a phase 1b study of its ...

Home > Pressemitteilung: Precision diagnostics using peptides: ...

Convergent Therapeutics Inc., a clinical-stage biotechnology company focused on the development of next-generation radiopharmaceuticals for the treatment of cancer, and NorthStar Medical Radioisotopes ...